RIO DE JANEIRO, BRAZIL - The drug Remdesivir, used against Ebola, is among the most studied to fight the symptoms caused by the novel coronavirus, as well as Chloroquine. Now, a study conducted by the University of Chicago and released by the Stat medical website, shows that Remdesivir helps in the recovery of patients who have developed the Covid-19 disease.
The treatment accelerates recovery from fever and respiratory symptoms, which has led to patients who took part in the study being released from the hospital in less than a week.
"The best news is that most of our patients have . . .